Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.05
-0.17 (-0.62%)
At close: Feb 9, 2026, 4:00 PM EST
27.01
-0.04 (-0.15%)
After-hours: Feb 9, 2026, 7:57 PM EST
Pfizer Stock Forecast
Stock Price Forecast
The 11 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $27.45, which forecasts a 1.48% increase in the stock price over the next year. The lowest target is $25 and the highest is $35.
Price Target: $27.45 (+1.48%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 7 | 9 | 10 | 10 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 9 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $27 | Hold | Reiterates | $27 | -0.18% | Feb 4, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $24 → $27 | Hold | Maintains | $24 → $27 | -0.18% | Jan 27, 2026 |
| UBS | UBS | Hold Initiates $25 | Hold | Initiates | $25 | -7.58% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $27 | Hold | Maintains | $28 → $27 | -0.18% | Dec 17, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +3.51% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
61.67B
from 62.58B
Decreased by -1.45%
Revenue Next Year
59.79B
from 61.67B
Decreased by -3.05%
EPS This Year
3.00
from 1.36
Increased by 120.12%
EPS Next Year
2.88
from 3.00
Decreased by -4.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 65.9B | 65.8B | |||
| Avg | 61.7B | 59.8B | |||
| Low | 58.4B | 56.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.3% | 6.7% | |||
| Avg | -1.4% | -3.0% | |||
| Low | -6.7% | -9.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.44 | 3.48 | |||
| Avg | 3.00 | 2.88 | |||
| Low | 2.74 | 2.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 152.4% | 15.7% | |||
| Avg | 120.1% | -4.0% | |||
| Low | 101.1% | -23.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.